CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2012
ASSETS
Cash and due from banks (Note 3)	$ 35,798	$ 24,139
Federal funds sold and interest bearing deposits in banks	19,156	6,520
Cash and cash equivalents	54,954	30,659
Securities available for sale, at fair value (Note 5)	223,173	203,763
Restricted stock	5,741	5,741
Loans held for sale	6,250	7,634
Loans:
Portfolio loans (Note 6)	889,931	882,548
Allowance for loan losses (Note 6)	(17,806)	(17,637)
Net loans	872,125	864,911
Bank premises and equipment, net	8,588	8,721
Other real estate owned	1,215	1,366
Bank owned life insurance	18,778	18,611
Goodwill, net (Note 4)	21,582	21,582
Intangible assets, net (Note 4)	561	594
Accrued interest receivable	4,018	3,726
Other assets	14,198	10,946
Total Assets	1,231,183	1,178,254
Deposits: (Note 7)
Demand and other noninterest-bearing	136,313	139,894
Savings, money market and interest-bearing demand	397,080	377,287
Time deposits	515,783	482,411
Total deposits	1,049,176	999,592
Short-term borrowings (Note 8)	1,889	1,115
Federal Home Loan Bank advances (Note 9)	46,557	46,508
Junior subordinated debentures (Note 10)	16,238	16,238
Accrued interest payable	828	882
Accrued expenses and other liabilities	6,290	3,775
Total Liabilities	1,120,978	1,068,110
Shareholders’ Equity
Discount on Series B preferred stock	(29)	(65)
Common stock, par value $1 per share, authorized 15,000,000 shares, issued 9,631,896 shares at March 31, 2013 and 8,272,548 at December 31, 2012	9,632	8,273
Additional paid-in capital	47,587	39,141
Retained earnings	49,551	48,767
Accumulated other comprehensive income	409	1,240
Treasury shares at cost, 328,194 shares at March 31, 2013 and at December 31, 2012	(6,092)	(6,092)
Total Shareholders’ Equity	110,205	110,144
Total Liabilities and Shareholders’ Equity	1,231,183	1,178,254
Preferred stock, Series A Voting, no par value, authorized 150,000 shares, none issued at March 31, 2013 and December 31, 2012.
Shareholders’ Equity
Preferred stock	0	0
Fixed rate cumulative preferred stock, Series B, no par value, $1,000 liquidation value, 9,147 shares authorized and issued at March 31, 2013 and 18,880 shares authorized and issued at December 31, 2012
Shareholders’ Equity
Preferred stock	$ 9,147	$ 18,880